China Pharma (NYSE:CPHI) Now Covered by StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a report released on Monday. The brokerage set a “hold” rating on the stock.

China Pharma Trading Down 6.6 %

Shares of NYSE:CPHI opened at $0.22 on Monday. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.41. The business’s 50 day simple moving average is $0.23 and its two-hundred day simple moving average is $0.22. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

See Also

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.